Proton Pump Inhibitorsare also instrumental in the management of peptic ulcers, which are open sores that develop on the lining of the stomach or the duodenum. These ulcers can be caused by infection with Helicobacter pylori bacteria or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs). PPIs are prescribed in combination with antibiotics to eradicate H. pylori infection, thereby facilitating the healing of peptic ulcers. In cases where ulcers are caused by NSAIDs, PPIs are used to prevent the recurrence of ulcers by reducing gastric acid secretion
Furthermore, Proton Pump Inhibitorsplay a crucial role in the treatment of Zollinger-Ellison syndrome (ZES), a rare condition characterized by the excessive production of gastric acid due to the presence of gastrin-secreting tumors called gastrinomas. These tumors stimulate the parietal cells to secrete large amounts of acid, leading to severe peptic ulcers and other gastrointestinal symptoms. PPIs are the primary treatment option for managing ZES, as they effectively suppress acid secretion and alleviate the associated symptoms.
Read More @ https://cmibloginsight.blogspot.com/2023/06/proton-pump-inhibitors-transforming.html
Comments
0 comment